News & Events

Real-World Examples of Patient Involvement in Designing Clinical Trials

Real-World Examples of Patient Involvement in Designing Clinical Trials

Read time: 2 minutes.Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials.  In the video below, LUNGevity again partnered with Rising Tide for Clinical Cancer Research to illustrate the power of having patients contribute to the research process. We use a real-world example to learn about patient-researcher collaborations through the POSITIVE study, a breast cancer-focused clinical trial. You can…

Developing Clinical Trials that Account for the Realities of Patient Life

Developing Clinical Trials that Account for the Realities of Patient Life

Read time: 2 minutes.  We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials.  In this second video, LUNGevity again partnered with Rising Tide for Clinical Cancer Research to show how researchers and patient advocates can be empowered with tools to create clinical trials that resonate with patients and address the key issues they care about.  If you missed the first video, How Can Patients…

Our Dream Was to Start a Family, but Lung Cancer Changed Everything

Our Dream Was to Start a Family, but Lung Cancer Changed Everything

Read time: 6 minutes. After a few unimpressive encounters I experienced in real life, I tentatively returned to the Match dating app. That’s where I stumbled upon a very sweet, kind-hearted, nerdy, and compassionate man. Then I met Nate (Ha! Just joking). It was Nate. We bonded so quickly during which we identified our life goals. One goal was to have a family.  Yes, we did the whole “let’s get ready” experience. We invested in a new SUV. We were eyeing new housing…

Team Develops Model to Enhance Prediction of KRAS Mutations in Patients With NSCLC

Team Develops Model to Enhance Prediction of KRAS Mutations in Patients With NSCLC

The 5 Most Popular Lung Cancer Blogs From 2024

The 5 Most Popular Lung Cancer Blogs From 2024

Read time: 3 minutes. Throughout 2024 we published blogs sharing scientific meeting recaps, educational content, personal stories, treatment news, and so much more. Below are the most popular articles we published in 2024. If you’re looking for survivor features and personal stories, you can see all the lung cancer survivors we highlighted in 2024 right here.   2024 ASCO: Highlights of Lung Cancer Research In June, we recapped the annual American Society of…

Boehringer and Vanderbilt scientists discover new GTPase KRAS inhibitors

Boehringer and Vanderbilt scientists discover new GTPase KRAS inhibitors

Revolution Medicines divulges new GTPase KRAS, NRAS and HRAS inhibitors

Revolution Medicines divulges new GTPase KRAS, NRAS and HRAS inhibitors

Breathe Easy: Navigating Stress Through the Holiday Season

Breathe Easy: Navigating Stress Through the Holiday Season

Our meetup on Wednesday, December 17, featured guest speaker Daniel Huvard, LCSW, of MD Anderson Cancer Center, who provided tips on managing stress during the holiday season while living with lung cancer. In case you missed the meetup, below is a short video Daniel recorded covering practical coping strategies to help you care for your well-being during this time.

Another pan-KRAS project enters the clinic

Another pan-KRAS project enters the clinic

Research Milestones: Celebrating LUNGevity’s 2024 Research Awards

Research Milestones: Celebrating LUNGevity’s 2024 Research Awards

LUNGevity had a tremendous year supporting impactful research in 2024. In addition to our existing portfolio of ongoing research grants, we issued several new research awards in 2024. All of these awards are in strategic areas of research that are likely to move the dial for people living with lung cancer today and those who will be diagnosed in the future.  Below are more details about the research projects we recently announced funding for. LUNGevity Supports 10 New Research…

Biagio Ricciuti: Discussing immunotherapy and targeted therapy for KRAS + NSCLC

Biagio Ricciuti: Discussing immunotherapy and targeted therapy for KRAS + NSCLC

Progress Against RAS-Driven Cancers Lauded at RAS Symposium, With More Candidate Treatments on Horizon

Progress Against RAS-Driven Cancers Lauded at RAS Symposium, With More Candidate Treatments on Horizon

Celebrating 20 Years of Progress in Lung Cancer Research and Treatment

Celebrating 20 Years of Progress in Lung Cancer Research and Treatment

Read time: 5 minutes.This year marks 20 years since researchers made a key discovery that changed the face of lung cancer research and treatment. By uncovering EGFR’s role in lung cancer, researchers developed a new class of drugs—targeted therapies—designed to target specific mutations in lung cancer cells while leaving healthy cells unharmed. As we’ve welcomed this era of precision medicine, we’ve also benefited from other treatment progress in lung cancer—including the development…

Lung cancer | Innovation and comprehensive care in the fight against lung cancer

Lung cancer | Innovation and comprehensive care in the fight against lung cancer

Brain Mets Basics for NSCLC: What Are Brain Metastases and How Do We Treat Them?

Brain Mets Basics for NSCLC: What Are Brain Metastases and How Do We Treat Them?

Read time: 2 minutes.  Brain metastases (also called brain mets) develop when cancer from somewhere else in the body spreads to the brain.  Over time, tumors can become metastatic (travel to other parts of the body). When lung cancer travels to the brain, it requires specialized treatments that can cross the blood-brain barrier. The blood-brain barrier is a tight network of blood vessels and tissue that allows some substances, such as oxygen and water, into the brain while…

MD Anderson Researchers Identify NSCLC Patients Suited to Dual Immune Checkpoint Blockade

MD Anderson Researchers Identify NSCLC Patients Suited to Dual Immune Checkpoint Blockade

Screening and Early Detection of Lung Cancer: Highlights from WCLC and ESMO 2024

Screening and Early Detection of Lung Cancer: Highlights from WCLC and ESMO 2024

Lung cancer screening and early detection were major topics of discussion at the World Conference on Lung Cancer (WCLC), held in San Diego from September 7-10, and the European Society for Medical Oncology (ESMO) conference in Barcelona from September 13-17. This fourth and final blog in our series of updates summarizes highlights from these discussions. You can read the other update blogs from these fall science meetings: Metastatic NSCLC Highlights  Small Cell Lung Cancer…

Metastatic Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

Metastatic Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

This year, the first three weeks of September were packed with lung cancer research updates at the World Conference on Lung Cancer (WCLC) from September 7-10 in San Diego followed by the European Society for Medical Oncology (ESMO) conference from September 13-17 in Barcelona.  We wish we could have cloned ourselves and been in both places; however, we were able to attend WCLC in person and ESMO virtually. It’s impossible to condense so much lung cancer science into a single blog, so…

Eating Healthy on the Mediterranean Diet

Eating Healthy on the Mediterranean Diet

Read time: 3 minutes.  Oncology dietitian Lori Bumbaco takes us on a culinary journey, exploring why experts consistently rank the Mediterranean diet as the number one choice for healthy eating. In addition to the studied health benefits, Lori highlights the unique foods and flavors that make this diet special and provides simple, practical tips on how to incorporate them into your daily meals. In the video below, Lori offers a firsthand look at how easy and enjoyable it can be…

New drug could help treat tough cancers, study finds

New drug could help treat tough cancers, study finds

How Do Drugs Get Approved (and Fast-Tracked) by the FDA?

How Do Drugs Get Approved (and Fast-Tracked) by the FDA?

Read time: 5 minutes.  This is Part 3 in our series on how drugs get approved to treat lung cancer.  Part 1: Understanding Clinical Trials - Why Are They Important for Drug Development? Part 2: How We Define Success for a Clinical Trial The United States federal government aims to regulate prescription drugs to ensure people are receiving medication that’s safe and effective. Every prescribed drug in the U.S. has gone through a rigorous testing process that can…

How We Define Success for a Clinical Trial

How We Define Success for a Clinical Trial

Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are important for new drug development. We all want a treatment for lung cancer that is completely safe and entirely effective. While researchers are working toward that goal, the reality is we aren’t there yet. Every treatment we are considering comes with potential benefits and side effects. The…

Understanding Clinical Trials: Why Are They Important for Drug Development?

Understanding Clinical Trials: Why Are They Important for Drug Development?

Read time: 3 minutes.This is Part 1 in a 3-part series explaining how new drugs and treatments get approved to treat lung cancer. Parts 2 and 3 will be published in the coming weeks.Have you ever wondered how a new medicine or drug to treat lung cancer is brought to the people who need it? That’s what clinical trials help us do.According to the National Cancer Institute, a clinical trial is a type of research study that tests how well new medical approaches (such as screening tests, prevention…

Countdown to ILCSC24: Bringing the World’s Experts Right to Your Living Room

Countdown to ILCSC24: Bringing the World’s Experts Right to Your Living Room

Read time: 3 minutes.  One of LUNGevity’s two flagship survivorship events, the International Lung Cancer Survivorship Conference (ILCSC), is being held virtually September 20 – 21, 2024. This is a free, online event that allows people with lung cancer and caregivers from around the world to join from the comfort of their own homes and hear from a star-studded lineup of lung cancer experts discussing the latest advances in research and treatment.  You can register today for…

How Can Patients and Researchers Design Clinical Trials Together?

How Can Patients and Researchers Design Clinical Trials Together?

Read time: 2 minutes.  Traditionally, people associate getting involved in lung cancer research with enrolling in a clinical trial. But most don’t realize they can also partner with researchers behind the scenes and get involved in designing clinical trials.  In the first of a three-part series, Rising Tide Foundation for Clinical Cancer Research has partnered with LUNGevity to understand the role people with lung cancer can play in developing clinical trials. Through panelist…

2024 ASCO: Highlights of Lung Cancer Research

2024 ASCO: Highlights of Lung Cancer Research

Read time: 8 minutesThousands of oncologists, scientists, biotech and pharmaceutical representatives, patients, and advocates (including LUNGevity staff) met to discuss lifesaving cancer research at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 31 through June 4, 2024. The theme for this year’s conference, “The Art and Science of Cancer Care: From Comfort to Cure,” highlighted the importance of using both our creativity and our scientific…

Researcher Aims to Bring 360-Degree Care to Young Adults Living with Lung Cancer

Researcher Aims to Bring 360-Degree Care to Young Adults Living with Lung Cancer

Young adults (less than 50 years of age) are being diagnosed with lung cancer at increasing rates. They tend to be women of Hispanic or Asian descent and are typically diagnosed with advanced-stage lung cancer. Research is ongoing to help us develop effective options to treat these patients medically, but little is known about the effects of the diagnosis on their mental, social, and financial health or their family planning. To help us better understand the needs of this growing…

Advice and Insights from Author and Two-Time Cancer Survivor Kathy Giusti

Advice and Insights from Author and Two-Time Cancer Survivor Kathy Giusti

Kathy Giusti joined LUNGevity for a special conversation about her life as a cancer patient, caregiver, and the founder and former CEO of the Multiple Myeloma Research Foundation. Her involvement with the medical system from these different perspectives inspired her to write her recent book, Fatal to Fearless: 12 Steps to Beating Cancer in a Broken Medical System. You can watch the full 40-minute conversation with Kathy or use the timestamps below to learn more about the topics and advice…

Safely Bring Yoga, Dietary Supplements, Exercise, and More into Your Lung Cancer Journey

Safely Bring Yoga, Dietary Supplements, Exercise, and More into Your Lung Cancer Journey

Read time: 2 minutesIntegrative oncology adds holistic approaches—such as acupuncture, nutrition, exercise, and mindfulness—into a treatment plan. Research shows these interventions can have a tremendous impact on people going through lung cancer treatment and their quality of life. Unfortunately, they are also topics riddled with myths and falsehoods. LUNGevity spoke to an expert to help sort out the facts from the fiction. In the webinar below, Gabriel Lopez, MD, medical director of…

Highlights of AACR 2024: Where the Laboratory Meets the Patient

Highlights of AACR 2024: Where the Laboratory Meets the Patient

Read time: 7 minutesIt’s spring! The daffodils bloom, the days become longer, and I attend the annual meeting of the American Association for Cancer Research (AACR). For those of you who are new to this meeting, it is the largest gathering of laboratory scientists and clinicians in the world—coming together to discuss how to take science from the bench (laboratory) to patients and communities. This year’s meeting was held in sunny San Diego and brought together more than 23,000 attendees. Below…